Fact CheckerSign in

NCT06331338Recruiting

Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes

Research on the Effectiveness of Using Decision Cycle for Person-Centered Glycemic Management on Self-Care Behaviors in Outpatients With Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 12 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Decision cycle for person-centered glycemic management is a new diabetes decision making .It is defined as a purposefully designed holistic care intervention .The goal is to improve the self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin levels and delaying the occurrence of complications.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
130 (estimated)
First submitted
20 Mar 2024
Start date
14 Feb 2024
Primary completion date
31 Oct 2025
Lead sponsor
National Taiwan University Hospital
NCT number
NCT06331338

What you commit to

  • Study type: Interventional
  • Planned participants: 130
  • From 14 Feb 2024 to the primary completion date, 31 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients diagnosed with type 1 diabetes by a physician.
  • Those who replaced oral diabetes medications, insulin and glucagon-like peptide- 1 at the outpatient at the time of admission.

Lab values

  • Glycated hemoglobin test value: less than 7.5 % and greater than 9.0 %

Age

  • Age: Under 18 years old.

Other

  • Pregnancy during the study period.
  • Those who are unable to take care of themselves and express themselves.

Who the study is looking for

  • Patients diagnosed with type 2 diabetes by a physician.
  • Age: 18 years or above.
  • Glycated hemoglobin (HbA1c ) test value: 7.5-9.0 %
  • No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted.
  • No pregnancy during the study period.
  • After the researcher explains the purpose of the research, the research subjects agree to join this researcher.
  • Those who are conscious and able to take care of themselves.
  • There is no diagnostic certificate from the American Psychiatric Association's Diagnostic Manual of Mental Disorders, Fourth Edition (DSM-IV)of all mental illnesses.
  • Those who can communicate in Mandarin and Taiwanese.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
HsinchuTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.